North America Acute Ischemic Stroke Diagnosis and Treatment Market by Diagnostic Type (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography and Nuclear Imaging) by Surgery Type (Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) and by Region- Industry Analysis, Size, Share, Growth, Trends, and Forecasts(2016–2021)

North America Acute Ischemic Stroke Diagnosis and Treatment Market by Diagnostic Type (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography and Nuclear Imaging) by Surgery Type (Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy) and by Region- Industry Analysis, Size, Share, Growth, Trends, and Forecasts(2016–2021)

ID: 266 | Pages: 137 | December 2016 | Region: North America


The North America Acute Ischemic Stroke Treatment and Diagnosis Market was worth $671.18 million in 2015 and estimated to be growing at a CAGR of 6.2%, to reach $906.7 million by 2020. Acute Ischemic stroke can be defined as loss of function in certain parts of brain due to lack of blood supply to the brain.

North America Acute Ischemic Stroke and Diagnosis and treatment is driven by factors such as rising prevalence of acute ischemia stroke cases, technological advancements in surgical procedures along with rising aging population, increased demand for minimally invasive procedures and growth in healthcare spending. Favourable government policies are also boosting the growth of the market in this region where as excessive usage of medication for the treatment of ischemic stroke and high cost of surgical procedures are restraining the growth of the market.

North America Acute Ischemic Stroke Diagnosis and Treatment Market is segmented into Diagnostic type and Surgery type. Diagnostic type segment is further sub-segmented into Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Cerebral angiography and nuclear imaging. On the Basis of Surgery Type the market is sub-segmented into Carotid Endarterectomy, Angioplasty and Endovascular Mechanical Thrombectomy. Carotid Endarterectomy is the largest segment accounting for a share of approximately XX% due to its high success rate, short treatment duration and easy availability.

On the basis of geography North America Acute Ischemic Stroke Diagnosis and Treatment Market is analysed under two regions namely United States and Canada. United States is the largest market for Acute Ischemic Stroke Diagnosis and Treatment devices accounting for a share of approximately XX% in 2015 and is estimated to continue its strong hold of the market owing to favourable government initiatives, technological innovations and increasing demand for ischemic stroke products.

 

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 Diagnostic Type                                                                        

                                5.1.1 Computed Tomography                                                    

                                5.1.2 Magnetic Resonance Imaging                                                         

                                5.1.3 Ultrasound                                                              

                                5.1.4 Cerebral angiography                                                         

                                5.1.5 Nuclear Imaging                                                    

                5.2 Surgery Type                                                                             

                                5.2.1 Carotid Endarterectomy                                                    

                                5.2.2 Angioplasty                                                             

                                5.2.3 Endovascular Mechanical Thrombectomy                                                 

6. Geographical Analysis                                                                                              

                                6.1 Introduction                                                               

                                6.2 United States                                                            

                                6.3 Canada                                                         

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 Abbott Laboratories                                                                               

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Covidien plc                                                                

                8.3 Johnson & Johnson                                                                 

                8.4 Penumbra, Inc.                                                                         

                8.5 Philips Healthcare                                                                    

                8.6 GE Healthcare                                                                           

                8.7 Hitachi, Ltd.                                                                

                8.8 Siemens Healthcare                                                                

                8.9 Stryker Corporation                                                                

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Acute Ischemic Stroke Diagnosis Market By Region, From 2015-2020 (USD Million)
  2. North America Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2015-2020 (USD Million)
  3. North America Computed Tomography Market By Region, From 2015-2020 (USD Million)
  4. North America Magnetic Resonance Imaging Market By Region, From 2015-2020 (USD Million)
  5. North America Ultrasound Market By Region, From 2015-2020 (USD Million)
  6. North America Cerebral angiography Market By Region, From 2015-2020 (USD Million)
  7. North America Nuclear Imaging Market By Region, From 2015-2020 (USD Million)
  8. North America Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2015-2020 (USD Million)
  9. North America Carotid Endarterectomy Market By Region, From 2015-2020 (USD Million)
  10. North America Angioplasty Market By Region, From 2015-2020 (USD Million)
  11. North America Endovascular Mechanical Thrombectomy Market By Region, From 2015-2020 (USD Million)
  12. United States Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2015-2020 (USD Million)
  13. United States Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2015-2020 (USD Million)
  14. Canada Acute Ischemic Stroke Diagnosis Market By Diagnostic Type, From 2015-2020 (USD Million)
  15. Canada Acute Ischemic Stroke Diagnosis Market By Surgery Type, From 2015-2020 (USD Million)
Middle East And Africa Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid T...
Latin America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Asia Pacific Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And ...
Europe Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others...
North America Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And...
Non-Invasive Cancer Diagnostics Market By Techniques (Clinical Chemistry, Immunochemistry, Molecular Diagnostics And Others), By Therapeutics (Blood Cancer, Breast Cancer, Lung Cancer, Solid Tumors And Others) And B...
Middle East And Africa Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) B...
Latin America Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) By Diagnos...
Asia Pacific Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) By Diagnost...
Europe Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) By Diagnostic Tec...
North America Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) By Diagnos...
Lyme Disease Diagnostic Market By Diagnostic Tests (Dark Field Microscopy, Urine Antigen Tests, Lymphocytic Transformation Test, Serological Tests, Immunofluorescence Staining And PCR Tests) By Diagnostic Technologi...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.